Please try another search
© Reuters. FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration
NEW YORK (Reuters) - Unprecedented quantities of vaccines could be produced by 28 manufacturers in 10 countries over the next two years to tackle the COVID-19 pandemic, the U.N. children's agency UNICEF said on Thursday, as it announced it would help lead efforts to procure and distribute them.
UNICEF's role is part of a COVID-19 vaccine allocation plan - known as COVAX and co-led by the World Health Organization - that aims to buy and provide equitable access to the shots. So far, 76 wealthy nations committed to joining the COVAX effort.
UNICEF said the 28 vaccine manufacturers had shared their annual productions plans for COVID-19 vaccines through 2023. A UNICEF market assessment "revealed that manufacturers are willing to collectively produce unprecedented quantities of vaccines over the coming 1-2 years."
But drugmakers have signaled the projections are "highly dependent on, among other things, whether clinical trials are successful, advance purchase agreements are put in place, funding is confirmed, and regulatory and registration pathways are streamlined."
Safe and effective vaccines are seen as essential to ending a pandemic that has so far claimed more than 864,000 lives globally.
UNICEF's new role with COVAX stems from its status as the largest single vaccine buyer in the world. The U.N. agency said it procures more than 2 billion doses of vaccines annually for routine immunization and outbreak response on behalf of nearly 100 countries.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.